Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Novabridge Biosciences (IMAB)

47 + Investors. Track Smart Money conviction in IMAB. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -10
Streak
1Q ▼
Buyers last Q
43%

Smart Money Signals — IMAB

Based on 47 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their IMAB positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 82% of 3.0Y peak

82% of all-time peak
47 funds currently hold this stock — 82% of the 3.0-year high of 57 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +57% more funds vs a year ago

fund count last 6Q
+17 new funds entered over the past year (+57% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 4 quarters from the low — a sharp move.
🟠

More sellers than buyers — 43% buying

24 buying32 selling
Last quarter: 32 funds reduced or exited vs 24 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-12 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 10 → 22 → 20 → 8. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 38% long-term, 32% new

■ 38% conviction (2yr+) ■ 30% medium ■ 32% new
Of the 47 current holders: 18 (38%) held >2 years, 14 held 1–2 years, and 15 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares -12%, value -46%

Value
-45%
Shares
-11%
Last quarter: funds added -12% more shares while total portfolio value only changed -46%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~8 new funds/quarter

6 → 10 → 22 → 20 → 8 new funds/Q
New funds entering each quarter: 10 → 22 → 20 → 8. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 60% veterans vs 30% newcomers

■ 60% veterans ■ 11% 1-2yr ■ 30% new
Entry-cohort mix of 47 holders: 28 (60%) are 2+ year veterans, 5 entered 1–2 years ago, and 14 (30%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
18 of 46 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in IMAB. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.2
out of 10
Moderate Exit Risk
Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IMAB

In 2026 Q1, 24 hedge funds were net buyers of IMAB (8 opened a new position, 16 added to an existing one), while 32 reduced or exited (14 trimmed, 18 sold completely) — a 43% buyer ratio, indicating roughly balanced activity. 40% of total institutional value in IMAB is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -10 funds (more exits than new entries). Total institutional holders: 47.

Hedge Fund Ownership: IMAB

How many hedge funds hold IMAB — quarterly history vs. share price
Quarterly hedge fund ownership of IMAB vs. share price

Market Analysis: IMAB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IMAB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 1 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
1.0
/ 10
conviction
Hedge Fund Positioning: IMAB
2026 Q2 Stats Unlock in 4 days 47 + Investors

Track Smart Money conviction in IMAB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 47 57 -17.54%
13F Shares 29M 33M -11.93%
Total Value $72M $132M -45.59%
New Positions 8 20 -12
Increased Positions 15 16 -1
Closed Positions 18 6 +12
Reduced Positions 14 13 +1
Total Calls 1 2 -50.0%
Total Puts 0 1 -100.0%
PUT/CALL Ratio 0.0 0.5 Bullish

Statistics: IMAB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

47 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IMAB. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 IMAB holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 AIHC Capital Management Ltd 5.38% 2,878,033 $5.6M
2 Hhlr Advisors, LTD. 1.40% 5,980,568 $11.7M
3 Exome Asset Management LLC 0.69% 576,960 $1.1M
4 Siren, L.L.C. 0.08% 2,004,739 $3.9M
5 Taikang Asset Management (Hong Kong) Co Ltd 0.03% 170,931 $333K
6 E Fund Management Co., Ltd. 0.03% 589,020 $1.1M
7 Headlands Technologies LLC 0.01% 65,183 $127K
8 Candriam S.C.A. 0.01% 1,132,563 $2.2M
9 Caitong International Asset Management Co., Ltd 0.01% 30,281 $59K
10 Aigen Investment Management, LP 0.01% 11,426 $22K
11 Adage Capital Partners GP, L.L.C. 0.00% 1,000,000 $1.9M
12 Two Sigma Securities, LLC 0.00% 15,641 $30K
13 Bronte Capital Management Pty Ltd. 0.00% 11,192 $22K
14 Fiera Capital Corp 0.00% 315,681 $616K
15 Woodline Partners LP 0.00% 350,000 $682K
16 China Universal Asset Management Co., Ltd. 0.00% 17,864 $35K
17 Renaissance Technologies LLC 0.00% 758,226 $1.5M
18 Marshall Wace, LLP 0.00% 1,231,946 $2.4M
19 Two Sigma Investments, LP 0.00% 851,348 $1.7M
20 Alps Advisors Inc 0.00% 117,096 $228K
21 Freestone Capital Holdings, LLC 0.00% 10,000 $20K
22 Morgan Stanley 0.00% 3,653,228 $7.1M
23 Tower Research Capital LLC (TRC) 0.00% 4,326 $8K
24 Citadel Advisors LLC 0.00% 622,831 $1.2M
25 Barclays plc 0.00% 279,019 $544K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Novabridge Biosciences (IMAB)

What does the Smart Money Trend signal show for IMAB?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their IMAB positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for IMAB?

More sellers than buyers — 43% buying: Last quarter: 32 funds reduced or exited vs 24 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for IMAB holders?

Elite ownership — 40% AUM from top-100 funds: 18 of 46 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in IMAB. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held IMAB?

Mixed — 38% long-term, 32% new: Of the 47 current holders: 18 (38%) held >2 years, 14 held 1–2 years, and 15 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →